Raymond DuBois Named Dean of MUSC College Of Medicine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

RAYMOND DUBOIS was named the next dean of The Medical University of South Carolina College of Medicine. DuBois will assume his new role effective March 1, 2016, with an academic appointment as professor while also holding an appointment in the Hollings Cancer Center.

DuBois currently serves as executive director of the Biodesign Institute at Arizona State University. Prior to his appointment at Arizona State, DuBois was provost and executive vice president at MD Anderson Cancer Center, overseeing all research, education, training and faculty development.

Prior to joining MD Anderson, DuBois was a professor at Vanderbilt University Medical Center in the departments of Internal Medicine and Cancer Biology, director of the Vanderbilt-Ingram Cancer Center, and prior to that, chief of Gastroenterology, Hepatology and Nutrition.

DuBois has served in many leadership roles, among them as past president of the American Association for Cancer Research and the International Society for Gastrointestinal Cancer. DuBois will continue his leadership in cancer discovery through his ongoing research, engagement with the NCI, and through partnership with the Hollings Cancer Center. He also currently serves on the Executive Management Committee for the Stand Up to Cancer Foundation, and is the president and chair of the AACR Foundation Board.

Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login